Category: Mesothelioma News

Patients with peritoneal mesothelioma undergoing a second cytoreductive surgery had a median survival of 92 months, according to a recent study at St. George Hospital and the University of South Wales in Sydney, Australia. That same group of patients also had a five-year survival rate of 71.8%, further illustrating the progress being made in treating…

The post Australian Study Shows Treatment Advances for Peritoneal Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Can I be a Kardashian?

The Baylor College of Medicine in Houston has opened its latest clinical trial for mesothelioma patients to study the effectiveness of a novel immunotherapy combination. The nonsurgical, single-center study is looking for a dozen patients whose pleural mesothelioma has progressed after at least one regimen of chemotherapy. The phase II clinical trial involves Opdivo (nivolumab)…

The post Baylor Opens New Immunotherapy Clinical Trial for Mesothelioma appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The Princess Margaret Cancer Center in Toronto has moved from SMART to SMARTER with the recent launch of its latest clinical trial for pleural mesothelioma patients. SMARTER is the acronym for Surgery for Mesothelioma After Radiation Therapy using Extensive pleural Resection, which also describes the latest clinical trial. The phase I clinical trial is an…

The post Mesothelioma Treatment in Toronto Moves from SMART to SMARTER appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The search for a cure of mesothelioma hit another roadblock recently when a once-promising immunotherapy drug, combined with standard chemotherapy, failed to slow disease progression in a phase III study. The multicenter study covering 27 countries involved Ofev (nintedanib), a small-molecule enzyme inhibitor drug that had shown considerable potential in earlier studies. Lancet Respiratory Medicine…

The post Once-Promising Drug Ofev Fails in Mesothelioma Clinical Trial appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

What happened in 1776?

Thoracic surgeon Dr. Robert Cameron, a longtime leader in the fight against pleural mesothelioma cancer, believes there is no benefit to establishing a government-funded national registry for the disease. While many of his colleagues support the idea of creating the first National Mesothelioma Registry, Cameron feels the time, effort and money spent would be better…

The post Cameron Sees No Need for National Mesothelioma Registry appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

President Donald Trump on Monday signed legislation that will extend the September 11th Victim Compensation Fund until 2092. During the signing ceremony at the White House, Trump was surrounding by first responders, survivors and family members of several who died in the 2001 terrorist attack on the United States. The U.S. House of Representatives and…

The post Trump Signs 9/11 Victims Fund Extension appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Despite banning all forms and uses of asbestos 20 years ago, Great Britain still has one of the world’s highest rates of mesothelioma cancer, according to the government’s Health and Safety Executive report. The July 2019 report revealed the number of annual deaths from mesothelioma in the country still is peaking and expected to begin…

The post Mesothelioma Death Rate Still Rising in Great Britain appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

Prophylactic radiotherapy — once offered routinely after invasive procedures for pleural mesothelioma — is an unnecessary treatment for patients, according to the most recent study from the United Kingdom. Results from a large, multicenter clinical trial have shown the treatment — used regularly for almost two decades — does little to prevent chest-wall metastasis that…

The post Radiotherapy No Longer Routine for Mesothelioma Patients appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.

The U.S. Justice Department is conducting a criminal investigation to determine if Johnson & Johnson misled the public about the possible presence of asbestos fibers and the resulting cancer risk in its talcum powder. According to Bloomberg News, a federal grand jury is examining whether company officials knew and denied their product once contained trace…

The post J&J Faces Criminal Probe over Asbestos in Baby Powder appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.